Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COPD Exacerbations”

314 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 314 results

Not applicableLooking for participantsNCT07112235
What this trial is testing

Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive Pulmonary Disease Exacerbations to Develop Novel Therapies and Therapeutic Targets

Who this might be right for
COPD (Chronic Obstructive Pulmonary Disease)Rhinovirus InfectionExacerbation of COPD
Imperial College London 50
Not applicableUnknownNCT03701945
What this trial is testing

Pulmonary Rehabilitation Innovation and Microbiota in Exacerbations of COPD

Who this might be right for
COPD ExacerbationCOPD
Aveiro University 156
Not applicableEnded earlyNCT03079661
What this trial is testing

Impact of Air Quality on Exacerbations of COPD in the Somme

Who this might be right for
Acute Exacerbation Copd
Centre Hospitalier Universitaire, Amiens 179
Not applicableNot Yet RecruitingNCT06915688
What this trial is testing

A Study Comparing Doxycycline and Levofloxacin for Treating COPD Exacerbations

Who this might be right for
COPD
Amina Aslam 188
Not applicableStudy completedNCT03332394
What this trial is testing

COPD Care Model on Clinical and Patient-Reported Outcomes

Who this might be right for
COPD Exacerbation
Ottawa Hospital Research Institute 58
Post-approval studies (Phase 4)Study completedNCT01443845
What this trial is testing

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)

Who this might be right for
COPDCOPD ExacerbationLung Diseases+4 more
AstraZeneca 2,354
Not applicableStudy completedNCT00281229
What this trial is testing

T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic ObstructiveLung Diseases, Obstructive
University of Michigan 481
Post-approval studies (Phase 4)Study completedNCT04458636
What this trial is testing

Stratified TreAtment to Reduce Risk in COPD

Who this might be right for
COPD Exacerbation
University of Oxford 203
Not applicableEnded earlyNCT02798575
What this trial is testing

COPD Exacerbations

Who this might be right for
COPD
RWTH Aachen University 7
Testing effectiveness (Phase 2)WithdrawnNCT00446667
What this trial is testing

A Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPD

Who this might be right for
COPDExacerbation
Syntara
Not applicableUnknownNCT05019911
What this trial is testing

Prediction of Exacerbations and Management of COPD Patients With SAH Based on Millimeter Wave Radar Monitoring

Who this might be right for
COPDSleep Apnea Hypopnea SyndromeAcute Exacerbation of COPD
Peking University Third Hospital 922
Large-scale testing (Phase 3)Study completedNCT01782326
What this trial is testing

QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 3,362
Not applicableStudy completedNCT03110614
What this trial is testing

Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of COPD

Who this might be right for
Chronic Obstructive Pulmonary DiseaseDiastolic Dysfunction
University of Alabama at Birmingham 94
Not applicableUnknownNCT05814484
What this trial is testing

Role of Inhaler Adherence and Blood Eosinophil Count in Exacerbations of COPD

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAdherence, Treatment
University of Leicester 104
Not applicableStudy completedNCT02275078
What this trial is testing

Innovations in Treating COPD Exacerbations: Pilot Project on Action Plans Using New Technology.

Who this might be right for
COPD
McGill University Health Centre/Research Institute of the McGill University Health Centre 40
Not applicableLooking for participantsNCT07213128
What this trial is testing

Effect of IMT in Patients After Acute Exacerbations of COPD

Who this might be right for
Chronic Obstructive Pulmonary DiseasesCOPDSymptom Exacerbation
KU Leuven 358
Not applicableStudy completedNCT00671151
What this trial is testing

Effects of Low-Dose Theophylline During Chronic Obstructive Pulmonary Disease (COPD) Exacerbations

Who this might be right for
COPD
Hospital Universitari Son Dureta 35
Not applicableStudy completedNCT04532853
What this trial is testing

Optimizing Maintenance Therapy in COPD Patients

Who this might be right for
COPD
General Practitioners Research Institute 1,434
Large-scale testing (Phase 3)Study completedNCT06040086
What this trial is testing

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 1,454
Not applicableNot Yet RecruitingNCT07361653
What this trial is testing

The REVIVE Pivotal Study

Who this might be right for
COPD (Chronic Obstructive Pulmonary Disease)COPD ExacerbationsCOPD Patients+4 more
Ryme Medical, Inc. 300
Next Page